Oceania (exc. Australia and New Zealand) vs Uzbekistan: Proportion of the target population who received a 3rd dose of
Oceania (exc. Australia and New Zealand)
50.0%
in 2024
Uzbekistan
94.0%
in 2024
Oceania (exc. Australia and New Zealand) rank
33rd
Uzbekistan rank
36th
Proportion of the target population who received a 3rd dose of over time
- Oceania (exc. Australia and New Zealand)
- Uzbekistan
How they compare
Uzbekistan currently reports 94.0% against 50.0% in Oceania (exc. Australia and New Zealand), a difference of 44.0%.
That makes Uzbekistan's figure about 1.9 times Oceania (exc. Australia and New Zealand)'s.
Across all 8 years both countries report, Uzbekistan has been ahead every year.
Oceania (exc. Australia and New Zealand) ranks 33rd and Uzbekistan ranks 36th of 37 groups.
Uzbekistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Oceania (exc. Australia and New Zealand) | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 41.0% | 98.0% | 57.0% | Uzbekistan |
| 2020s | 44.8% | 96.6% | 51.8% | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Oceania (exc. Australia and New Zealand) or Uzbekistan?
- Uzbekistan, at 94.0% against 50.0% in Oceania (exc. Australia and New Zealand) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Oceania (exc. Australia and New Zealand) and Uzbekistan?
- 44.0%, with Uzbekistan ahead.
- How many years of comparable data are there for Oceania (exc. Australia and New Zealand) and Uzbekistan?
- 8 years are reported by both, from 2017 to 2024.
- How do Oceania (exc. Australia and New Zealand) and Uzbekistan rank globally for proportion of the target population who received a 3rd dose of?
- Oceania (exc. Australia and New Zealand) ranks 33rd and Uzbekistan ranks 36th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.